Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Landos Biopharma, Inc. LABP

Set alert

Price alert · LABP

All alert types
22.93 +22.93 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
71.68M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-11.08
Beta
0.00
Short ratio
0.08
Inst. own
52.04%
Dividend
0.00
Ex-div date
Earnings
May 9, 2024
50-d avg
20.19
200-d avg
8.35
1y target
12.71

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for LABP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-3.23 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2018: -79.5×FY 2019: -34.6×FY 2020: -16.0×FY 2021: -5.1×FY 2022: -0.5×FY 2023: -1.0×
FY 2018 5y median -5.1× FY 2023
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 10.7×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
P/B 0.7×
FY 2018: 481×FY 2019: -18.8×FY 2020: -8.9×FY 2021: 2.5×FY 2022: 0.5×FY 2023: 0.7×
FY 2018 5y median 0.5× FY 2023
P/FCF -1.1×
FY 2018: -69.3×FY 2019: -48.0×FY 2020: -20.8×FY 2021: -7.0×FY 2022: -0.4×FY 2023: -1.1×
FY 2018 5y median -7.0× FY 2023
EV/EBITDA 0.6×
FY 2018: -82.1×FY 2019: -36.1×FY 2020: -15.7×FY 2021: -4.8×FY 2022: 0.4×FY 2023: 0.6×
FY 2018 5y median -4.8× FY 2023
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 10.3×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
FCF Yield -89.1%
FY 2018: -1.4%FY 2019: -2.1%FY 2020: -4.8%FY 2021: -14.2%FY 2022: -227.4%FY 2023: -89.1%
FY 2018 5y median -14.2% FY 2023

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 98.9%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -215.6%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -212.4%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
ROE -69.0%
FY 2018: -604.4%FY 2019: 54.5%FY 2020: 55.8%FY 2021: -50.1%FY 2022: -97.1%FY 2023: -69.0%
FY 2018 5y median -50.1% FY 2023
ROIC -71.5%
FY 2018: -793.9%FY 2019: -28.0%FY 2020: -159.0%FY 2021: -50.6%FY 2022: -100.3%FY 2023: -71.5%
FY 2018 5y median -71.5% FY 2023
ROA -57.7%
FY 2018: -216.2%FY 2019: -27.6%FY 2020: -99.4%FY 2021: -41.2%FY 2022: -84.0%FY 2023: -57.7%
FY 2018 5y median -57.7% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%
FY 2018 FY 2023
Operating Income 44.0%
FY 2018: 0.0%FY 2019: -67.4%FY 2020: -130.8%FY 2021: -26.5%FY 2022: -4.5%FY 2023: 44.0%
FY 2018 FY 2023
EPS (diluted) 62.9%
FY 2018: 0.0%FY 2019: -129.8%FY 2020: -116.4%FY 2021: -26.5%FY 2022: 0.6%FY 2023: 62.9%
FY 2018 FY 2023
Free Cash Flow 55.3%
FY 2018: 0.0%FY 2019: -44.6%FY 2020: -130.7%FY 2021: -18.8%FY 2022: -66.5%FY 2023: 55.3%
FY 2018 FY 2023

Financial Health

Current Ratio 6.1×
FY 2018: 1.4×FY 2019: 16.6×FY 2020: 2.7×FY 2021: 5.5×FY 2022: 7.4×FY 2023: 6.1×
FY 2018 5y median 6.1× FY 2023
Quick Ratio 6.1×
FY 2018: 1.4×FY 2019: 16.6×FY 2020: 2.6×FY 2021: 5.5×FY 2022: 7.4×FY 2023: 6.1×
FY 2018 5y median 6.1× FY 2023
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
Net Debt / EBITDA 1.7×
FY 2018: 0.1×FY 2019: 0.8×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.9×FY 2023: 1.7×
FY 2018 5y median 0.8× FY 2023
Interest Coverage 0.0×
FY 2018: -1985×FY 2019: -43.7×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31